Molecular therapy set to protect at-risk patients against heart attack and stroke

March 30th, 2017 | Posted by admin in Uncategorized

Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol -- one of the main risk factors for heart attack and stroke -- conclude researchers.
Source: Care Giving Science Daily

You can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *